Organised by Nova Biomedical
Chair(s)
Mr Marcin Pacek, Senior Medical Director, Nova Biomedical, Spain
Introduction:
Attendees will learn how point of care diagnostics can be successfully used in pharmacy setting for management of most prevalent chronic diseases.
Programme:
| 08:00 – 08:02 | Chair introduction |
| Mr Marcin Pacek, Senior Medical Director, Nova Biomedical, Spain | |
| 08:02 – 08:17 | Pharmaceutical care program for patients with chronic kidney disease in the community pharmacy: Detection of nephrotoxic drugs and dose adjustment |
| Dr Luís Salar Ibáñez | |
| 08:17 – 08:32 | Chronic kidney disease screening in community using eGFR and uminuria/creatiniuria ratio by point of care testing: proof of concept | |
| Prof Cristol Jean-Paul, University of Montpellier, France | |
| 08:32 – 08:45 | RenAlert. A program designed for early detection of kidney disease and to inform at-risk groups of its potential consequences |
| Dr Juan Carlos Julian Mauro | |
| 08:45 – 08:50 | Closing |
Learn about the benefits of care diagnostic technologies available for chronic disease management in pharmacy setting.
2. Learn about integration of POC testing activities in pharmacies with hospital information systems and benefits it can provide.
3. Learn about opportunities and benefits POC testing in pharmacies offers to the health care system, as well as to improve population health.
Take home messages:
POC testing in pharmacies can improve chronic disease management in community settings.
Kidney function assessment using creatinine/eGFR measuring device can be very beneficial for medication optimization as well as for CKD screening in pharmacy settings
